25944-1-AP

antibody from Proteintech Group

Targeting: PTPN13 PTP-BAS, PTP-BL, PTP1E, PTPL1

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

25944-1-AP

Provider

Proteintech Group

Product name

PTPN13 antibody

Antibody type

Polyclonal

Description

KD/KO validated PTPN13 antibody (Cat. #25944-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC, WB, ELISA.

Reactivity

Human

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

Targeting PTPN13 with 11-amino-acid peptides of C-terminal APC prevents immune evasion of colorectal cancer.

Ma WH, Li WY, Chen T, Jing L, Chen YH, Li K, Xu ZL, Shen RF, He Y, Mou T, Luo TY, Sun X, Wu ZK, Wang LJ, Liu HJ, Qiu X, Gao Y, Bai X, Wang W, Wu D, Li G, Zhou WJ
Cell research 2026 Jan;36(1):72-93

---

Distinctive genes and signaling pathways associated with type 2 diabetes-related periodontitis: Preliminary study.

Duarte PM, Gurgel BCV, Miranda TS, Sardenberg J, Gu T, Aukhil I
PloS one 2024;19(1):e0296925

---

METTL1/FOXM1 promotes lung adenocarcinoma progression and gefitinib resistance by inhibiting PTPN13 expression.

Peng W, Fu J, Zhou L, Duan H
Cancer medicine 2024 Jul;13(13):e7420

---

PTPN13 Participates in the Regulation of Epithelial-Mesenchymal Transition and Platinum Sensitivity in High-Grade Serous Ovarian Carcinoma Cells.

Aptecar L, Puech C, Lopez-Crapez E, Peter M, Coopman P, D'Hondt V, Freiss G
International journal of molecular sciences 2023 Oct 21;24(20)

---

Direct conversion of human umbilical cord mesenchymal stem cells into retinal pigment epithelial cells for treatment of retinal degeneration.

Zhu X, Chen Z, Wang L, Ou Q, Feng Z, Xiao H, Shen Q, Li Y, Jin C, Xu JY, Gao F, Wang J, Zhang J, Zhang J, Xu Z, Xu GT, Lu L, Tian H
Cell death & disease 2022 Sep 12;13(9):785

---

Protein tyrosine phosphatase PTPL1 suppresses lung cancer through Src/ERK/YAP1 signaling.

Wang J, Li S, Zhang X, Zhu N, Yiminniyaze R, Dong L, Li C, Gulinuer W, Xia J, Li J, Zhou D, Liu X, Zhang Y, Zhang Y, Li S
Thoracic cancer 2022 Nov;13(21):3042-3051

---

Cancer-derived IgG involved in cisplatin resistance through PTP-BAS/Src/PDK1/AKT signaling pathway.

Wang LM, Gan YH
Oral diseases 2021 Apr;27(3):464-474